The University of Southampton
University of Southampton Institutional Repository

Engineering a HER2-specific antibody–drug conjugate to increase lysosomal delivery and therapeutic efficacy

Engineering a HER2-specific antibody–drug conjugate to increase lysosomal delivery and therapeutic efficacy
Engineering a HER2-specific antibody–drug conjugate to increase lysosomal delivery and therapeutic efficacy
We improve the potency of antibody–drug conjugates (ADCs) containing the human epidermal growth factor receptor 2 (HER2)-specific antibody pertuzumab by substantially reducing their affinity for HER2 at acidic endosomal pH relative to near neutral pH. These engineered pertuzumab variants show increased lysosomal delivery and cytotoxicity towards tumor cells expressing intermediate HER2 levels. In HER2int xenograft tumor models in mice, the variants show higher therapeutic efficacy than the parent ADC and a clinically approved HER2-specific ADC.
1087-0156
523-526
Kang, Jeffrey C.
a3dfd242-a85c-475e-9b98-a6a79db7a93c
Sun, Wei
000b1f51-3244-44c5-b309-54d3b01c9089
Khare, Priyanka
81db6b4f-ee24-4dcf-84e3-42b53f367cde
Karimi, Mostafa
2ecfafb4-a325-4392-b5d8-d4ff85f2c617
Wang, Xiaoli
b4716dc4-ee38-4e74-8690-1f027ccf080b
Shen, Yang
b62d5af5-48bc-41d1-88be-c364f6129a9f
Ober, R.J.
31f4d47f-fb49-44f5-8ff6-87fc4aff3d36
Ward, E. Sally
b31c0877-8abe-485f-b800-244a9d3cd6cc
Kang, Jeffrey C.
a3dfd242-a85c-475e-9b98-a6a79db7a93c
Sun, Wei
000b1f51-3244-44c5-b309-54d3b01c9089
Khare, Priyanka
81db6b4f-ee24-4dcf-84e3-42b53f367cde
Karimi, Mostafa
2ecfafb4-a325-4392-b5d8-d4ff85f2c617
Wang, Xiaoli
b4716dc4-ee38-4e74-8690-1f027ccf080b
Shen, Yang
b62d5af5-48bc-41d1-88be-c364f6129a9f
Ober, R.J.
31f4d47f-fb49-44f5-8ff6-87fc4aff3d36
Ward, E. Sally
b31c0877-8abe-485f-b800-244a9d3cd6cc

Kang, Jeffrey C., Sun, Wei, Khare, Priyanka, Karimi, Mostafa, Wang, Xiaoli, Shen, Yang, Ober, R.J. and Ward, E. Sally (2019) Engineering a HER2-specific antibody–drug conjugate to increase lysosomal delivery and therapeutic efficacy. Nature Biotechnology, 37 (5), 523-526. (doi:10.1038/s41587-019-0073-7).

Record type: Article

Abstract

We improve the potency of antibody–drug conjugates (ADCs) containing the human epidermal growth factor receptor 2 (HER2)-specific antibody pertuzumab by substantially reducing their affinity for HER2 at acidic endosomal pH relative to near neutral pH. These engineered pertuzumab variants show increased lysosomal delivery and cytotoxicity towards tumor cells expressing intermediate HER2 levels. In HER2int xenograft tumor models in mice, the variants show higher therapeutic efficacy than the parent ADC and a clinically approved HER2-specific ADC.

Text
Kang et al_021919_final - Accepted Manuscript
Download (250kB)
Text
Supplementary material - Other
Download (1MB)
Text
41587_2019_73_MOESM1_ESM
Restricted to Repository staff only
Request a copy

More information

Accepted/In Press date: 20 February 2019
e-pub ahead of print date: 1 April 2019
Published date: 1 April 2019

Identifiers

Local EPrints ID: 430711
URI: http://eprints.soton.ac.uk/id/eprint/430711
ISSN: 1087-0156
PURE UUID: e493e07e-3fd4-4de2-ae70-363a5a64d965
ORCID for R.J. Ober: ORCID iD orcid.org/0000-0002-1290-7430
ORCID for E. Sally Ward: ORCID iD orcid.org/0000-0003-3232-7238

Catalogue record

Date deposited: 08 May 2019 16:30
Last modified: 16 Mar 2024 07:38

Export record

Altmetrics

Contributors

Author: Jeffrey C. Kang
Author: Wei Sun
Author: Priyanka Khare
Author: Mostafa Karimi
Author: Xiaoli Wang
Author: Yang Shen
Author: R.J. Ober ORCID iD
Author: E. Sally Ward ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×